msg advisors
AI in the regulated GxP environment: Dr Hans Klöcker explains how pharmaceutical companies validate AI solutions and ensure safe, compliant operation.
msg advisors
Transparency for your processes: Use process mining to identify inefficiencies and optimisation potential in order to reduce costs and accelerate workflows.
msg advisors
Security for critical infrastructures: Learn how KRITIS guidelines and business continuity management interact in the pharmaceutical industry.
Article
Many companies only use a fraction of XM's potential. What needs to be changed?
Article
Process mining helps identify efficiency gaps in existing business processes. This benefits companies in two ways.
Article
End users as a “critical factor” for successful rollouts: What companies should pay attention to.
Article
Pharmaceutical companies need particularly responsive and professional emergency and crisis management.
Article
Transparent mapping, solid risk assessment, consistent monitoring, and targeted capability building help companies secure standards and seize opportunities. AI-powered tools add real-time visibility across the entire chain.